GlassScriptPhysician profile
Shanna Mago
NPI 1689918849
$5,445.54
in general payments reported to CMS, 2019-2025
20 companies · $2,034 in 2025
The $2,034 reported for 2025 was more than what 92% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.95 · 2022: $433 · 2023: $1,052 · 2024: $1,828 · 2025: $2,034.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,901 · Education: $12.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,901.12 |
| Education | $12.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $910.88 | 2023-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $748.12 | 2022-2025 | Caplyta |
| Alkermes, INC. | $503.91 | 2022-2025 | Lybalvi, Aristada |
| Otsuka America Pharmaceutical, INC. | $417.89 | 2021-2025 | Rexulti |
| Tris Pharma INC | $410.06 | 2022-2025 | Dyanavel Xr, Quillichew Er, Quillivant |
| Janssen Pharmaceuticals, INC | $342.79 | 2023-2025 | Spravato |
| Supernus Pharmaceuticals, INC. | $280.23 | 2022-2025 | Qelbree |
| Lundbeck LLC | $232.72 | 2022-2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $217.14 | 2024-2025 | Cobenfy |
| Vanda Pharmaceuticals INC. | $206.91 | 2024-2025 | Fanapt |
| Neos Therapeutics, LP | $193.08 | 2022-2025 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Noven Therapeutics, LLC | $190.97 | 2023-2025 | Xelstrym, Secuado |
| Teva Pharmaceuticals USA, INC. | $156.18 | 2022-2024 | Uzedy |
| Corium, LLC | $154.17 | 2024-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $111.79 | 2022-2025 | Trintellix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $93.50 | 2023-2025 | Auvelity |
| Collegium Pharmaceutical, INC. | $89.81 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $88.42 | 2022-2024 | |
| Almatica Pharma LLC | $75.97 | 2025 | Loreev Xr |
| Avion Pharmaceuticals | $21.00 | 2023 | Methylphenidate Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shanna Mago listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.